Experience of treatment of patients with chronic cerebral ischemia stages I–II on the background of hypertension with Reosorbilakt
The article presents the results of study of 60 patients with chronic cerebral ischemia I–II stages and arterial hypertension. All patients were divided into 2 groups. In group 1 (basic) we included 30 patients who at a background of baseline therapy received reosorbilakt 200.0 ml intravenous drip for 5 days. Group 2 (control group) consisted of 30 patients who received only standard therapy. All patients underwent a thorough clinical and neurological examination. Indicators of severity of headache was assessed using visual analogue scale (VAS), to identify autonomic disorders and determining vegetative dystonia syndrome (VDS) have been used a questionnaire and circuit, the severity of autonomic reactivity by Danini-Aschner, to assess an anxiety Hamilton test was used. The effectiveness of reosorbilakt with basic therapy was proven by improvements in headache severity by VAS, VDS, the vegetative reactivity Danini – Aschner and performance anxiety in Hamilton test.